Topotecan Completed Phase 2 Trials for Neuroblastomas / Sarcomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01492673Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
NCT00003745Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
NCT00040872Multiple Therapies in Treating Patients With Advanced Neuroblastoma
NCT00135135Therapy for Children With Neuroblastoma
NCT00186849Therapy for Children With Advanced Stage High Risk Neuroblastoma
NCT00960739Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma